Lobeglitazone is a thiazolidinedione derivative and insulin sensitizer indicated for the management of type 2 diabetes mellitus by enhancing peripheral glucose uptake. Within this category, researchers… Read more




Lobeglitazone is a thiazolidinedione derivative and insulin sensitizer indicated for the management of type 2 diabetes mellitus by enhancing peripheral glucose uptake. Within this category, researchers and pharmaceutical laboratories can access a comprehensive range of reference standards, including the parent drug, its known impurities, degradation products, and stable isotope-labelled compounds. These high-quality materials are essential for rigorous impurity profiling, accurate method validation, and ongoing quality control testing. By utilizing these precisely characterized reference standards—such as dehydro and desmethyl variants—analytical chemists can ensure compliance with regulatory guidelines while monitoring stability and safety throughout the drug development lifecycle. The inclusion of stable isotope-labelled lobeglitazone compounds further supports precise quantitative analysis in complex matrices, providing the necessary tools for both pharmacopeial and non-pharmacopeial investigations into this therapeutic agent.